We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Fireangel Safety Technology Group Plc | FA. | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
7.25 | 7.25 |
Industry Sector |
---|
ELECTRONIC & ELECTRICAL EQUIPMENT |
Top Posts |
---|
Posted at 16/7/2024 13:29 by tiswas Thanks guys. iDealing have not credited me with the funds for a small number of warrants I hold so I will chase them for that.I wonder if we will see FA relisted in a few years time? |
Posted at 08/12/2023 16:27 by harrogate FA have been selling Chinese units for ages. And the buyer is Singapore based. |
Posted at 24/11/2023 10:31 by billybunter1970 What about Resideo? I'm really surprised they haven't made a counter offer, even if to just buy the European sales book and to utilise the FA Cloud infrastructure. |
Posted at 24/11/2023 10:25 by harrogate Downing said in their own fund update that FA offer level was disappointing but they supported it. I would have thought there will be no higher offer unless the old trade shareholder steps up and given they didn't support the last raise I would doubt that happening. |
Posted at 23/11/2023 15:33 by gnnmartin Thanks for the warrant update. Very fair.Billy, I think you can accept for the warrants and not for the shares, but I think it unlikely that the shares will remain listed. Most likely is that the more than 90% of shares accept the offer, in which case Siterwell will compulsorily purchase the remaining shares. If Siterwell get less than 90% acceptances, then they might abandon the bid, in which case no shares or money changes hands. Or if Siterwell get less than 90% but more than (IIRC) 50%, they might go unconditional, in which case those shares & warrants that have been offered will be bought, and those that haven't will remain with the current holder. In that last case, and just possibly in the first too, it is possible that Siterwell will just run .FA with the remaining shareholders in place. If they do that, it is likely they will delist the shares. |
Posted at 28/10/2023 19:02 by hedgehog 100 Well done to FA. shareholders on trebling their money overnight.This bodes well for Parity (PTY): market cap. £1.91M. at 1.85p, 2022 revenue £40.6M. PTY's net debt as at 30.6.23 was only £0.7M., and the company was close to EBITDA break-even. PTY may well currently be considering takeover overtures. |
Posted at 25/5/2023 14:41 by emperors tailor Mmmm...I have been watching FA for over 20 years. You can rely 100% on 1. Issue more shares to raise cash 2. Pay the Directors handsomely. I guess some shareholders are so far in that pulling out will be more painful than staying in.And so it goes on.These are low value consumer products with competition from all sides. |
Posted at 18/5/2023 10:01 by epo001 You NEVER recover losses on that scale. Avoid the sunk cost fallacy. Even if the price comes back you are just back to where you started whereas others stocks have grown, so you're still behind.Either leave the money where it is if you strongly believe there will be a recovery or cash in and put the money into a stock which has better growth or dividend prospects. Not a holder but watching from the sidelines because there might have been a buying opportunity, that opportunity seems to be galloping into the distance leaving a cloud of dust behind it. |
Posted at 17/5/2023 08:29 by billybunter1970 JC has been at FA a few years now and not had any positive impact on shareholder value....so far. Hopefully they are delaying published results, pending some big positive news. |
Posted at 11/5/2023 16:25 by yasx FA seem to find every reason to explain unrelenting poor performance. Every update offers an excuse in mitigation with the promise of a remedy. The following update then offers a separate reason for failure.Fa announcements are like a medicine. Every time you are given one, another side effect appears. Nothing is cured...eventually the patient dies. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions